Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

157
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
157
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

187
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
187
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

890
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
890
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

154
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
154
Dementia01:30

Dementia

463
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
463

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9-Year Nationwide Analysis in France.

Movement disorders clinical practice·2026
Same author

Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis.

EClinicalMedicine·2026
Same author

Do sex differences in dementia with Lewy bodies arise from Alzheimer's disease biological profile?

Journal of Alzheimer's disease : JAD·2025
Same author

MRI-derived atrophy in multiple system atrophy aligns with mitochondrial and glial gene expression patterns.

NPJ Parkinson's disease·2025
Same author

Reply to: Deep Learning to Differentiate Parkinsonian Syndromes: From Proof of Concept to Clinical Trust.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment.

Scientific reports·2025

Related Experiment Video

Updated: Jan 1, 2026

Behavioral Assessment of the Aging Mouse Vestibular System
09:30

Behavioral Assessment of the Aging Mouse Vestibular System

Published on: July 11, 2014

17.5K

[Movement disorders in the elderly].

Jennifer Doridam1, Marie Mongin1, Bertrand Degos2

  • 1Service de neurologie, Hôpital Avicenne, Hôpitaux Universitaires de Paris - Seine-Saint-Denis, Paris, Bobigny, France, Faculté de médecine, Université Paris 13, UFR SMBH 74, Bobigny, France.

Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement
|December 19, 2019
PubMed
Summary
This summary is machine-generated.

Movement disorders are common in older adults, impacting their independence. This review covers frequent types, causes like medications, and essential diagnostic approaches for better management.

Keywords:
adverse drug reactionelderlymovement disorderstremor

More Related Videos

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

629
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
04:13

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults

Published on: February 8, 2019

7.1K

Related Experiment Videos

Last Updated: Jan 1, 2026

Behavioral Assessment of the Aging Mouse Vestibular System
09:30

Behavioral Assessment of the Aging Mouse Vestibular System

Published on: July 11, 2014

17.5K
A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

629
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
04:13

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults

Published on: February 8, 2019

7.1K

Area of Science:

  • Geriatrics
  • Neurology

Background:

  • Movement disorders are prevalent in the elderly population.
  • These conditions significantly affect patient autonomy and quality of life.

Purpose of the Study:

  • To review the most common movement disorders in the elderly.
  • To highlight diagnostic considerations and treatment strategies.

Main Methods:

  • Literature review focusing on frequent movement disorders in the elderly.
  • Emphasis on clinical examination for diagnosis.
  • Exploration of iatrogenic and metabolic causes.

Main Results:

  • Tremor, including essential tremor and Parkinson's disease, is the most frequent type.
  • Medication-induced movement disorders are common, particularly in elderly patients with renal or hepatic impairment.
  • Various other causes and their treatments are discussed.

Conclusions:

  • Accurate diagnosis of movement disorders in the elderly is crucial for maintaining autonomy.
  • Identifying iatrogenic or metabolic causes is essential.
  • Treatment decisions weigh functional gain against iatrogenic risk in frail individuals.